Pharma Insights
Access drug pipeline data, epidemiology insights, and therapeutic area analysis. Track 12 drugs across clinical stages with $27.4B+ projected market value.
Filter by Therapeutic Area:
Drug Pipeline Overview
Drugs organized by clinical development stage
1
Preclinical
2
Phase I
2
Phase II
4
Phase III
3
Approved
Showing 12 of 12 drugs
Cardioprotect
cardioprotectol
HeartMed Labs • Cardiovascular
Cardiozen
cardiozepam
HeartMed Labs • Cardiovascular
Immunoboost
immunobostatin
ImmunoTech • Immunology
Immunoshield
immunoshieldab
ImmunoTech • Immunology
Metabalance
metabalancin
MetaHealth • Metabolic Disorders
Neuroguard
neuroguardine
BrainScience Corp • Neurology
Neurovex
neurovexine
BrainScience Corp • Neurology
Oncorix
oncorizumab
PharmaCorp Inc • Oncology
Oncotarget
oncotargetinib
CancerFight Labs • Oncology
Raritex
raritexumab
OrphanDrug Co • Rare Diseases
Respiraflow
respirafloxacin
LungCare Pharma • Respiratory
Viralstop
viralstopivir
AntiViral Inc • Infectious Disease
Pharma Insights Overview
12
Drugs Tracked
3
Approved Drugs
8
Therapeutic Areas
$27.4B
Projected Revenue
Browse by Therapeutic Area
About Pharma Insights
Drug Pipeline
Track drugs across all clinical stages from preclinical to market approval.
Therapeutic Areas
Filter by therapeutic area to focus on specific disease categories.
Epidemiology Data
Access prevalence and incidence rates by region for key diseases.
Market Projections
View estimated revenue and peak sales projections for each drug.